Today, the CEO of Resmed Inc (RMD), Michael J. Farrell, sold shares of RMD for $344.8K.
Following Michael J. Farrell’s last RMD Sell transaction on November 01, 2017, the stock climbed by 18.1%. This is Farrell’s first Sell trade following 15 Buy transactions.
See today’s analyst top recommended stocks >>
Based on Resmed Inc’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $588 million and quarterly net profit of $106 million. In comparison, last year the company earned revenue of $524 million and had a net profit of $86.13 million. RMD’s market cap is $14.62B and the company has a P/E ratio of 44.21. Currently, Resmed Inc has an average volume of 467.4K.
Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $94.50, reflecting a -7.1% downside.
In the last 30 days, insiders have sold $780.1K worth of RMD shares and purchased $144.3K worth of RMD shares.
Michael J. Farrell’s trades have generated a 4.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
